|
(AFX UK Focus)
2009-10-06 12:27
BRIEF-Biovail gives update on pimavanserin development program |
|---|
| Article layout: raw |
|
Oct 6 (Reuters) - Biovail Corp:
development of pimavanserin schizophrenia as third indication ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here)
COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. |
| Re-organisations, re-structurings, name changes, AGM, EGM |
| Article layout: raw |
|